Potassium-sparing diuretics work by reducing sodium absorption in the collecting tubules and ducts of the kidney, thereby reducing loss of potassium in the urine. The two main types are mineralocorticoid receptor antagonists like spironolactone and eplerenone, which bind to receptors to blunt aldosterone activity, and ENAC channel blockers like amiloride and triamterene, which directly interfere with sodium entry through epithelial sodium channels. Toxicities can include hyperkalemia, hyperchloremic metabolic acidosis, and kidney stones.
Potassium-sparing diuretics work by reducing sodium absorption in the collecting tubules and ducts of the kidney, thereby reducing loss of potassium in the urine. The two main types are mineralocorticoid receptor antagonists like spironolactone and eplerenone, which bind to receptors to blunt aldosterone activity, and ENAC channel blockers like amiloride and triamterene, which directly interfere with sodium entry through epithelial sodium channels. Toxicities can include hyperkalemia, hyperchloremic metabolic acidosis, and kidney stones.
Potassium-sparing diuretics work by reducing sodium absorption in the collecting tubules and ducts of the kidney, thereby reducing loss of potassium in the urine. The two main types are mineralocorticoid receptor antagonists like spironolactone and eplerenone, which bind to receptors to blunt aldosterone activity, and ENAC channel blockers like amiloride and triamterene, which directly interfere with sodium entry through epithelial sodium channels. Toxicities can include hyperkalemia, hyperchloremic metabolic acidosis, and kidney stones.
Mineralocorticoid receptor antagonist Spironolactone --Primary aldosteronism (Conn’s -reduce Na + absorption in the collecting Hyperkalemia syndrome, tubules and ducts. Hyperchloremic Metabolic Acidosis ectopic adrenocorticotropic -Potassium absorption (and K + secretion) Gynecomastia hormone production) at this site is regulated by aldosterone Acute Renal Failure Eplerenone --secondary hyperaldosteronism -Spironolactone and eplerenone bind to Kidney Stones (evoked by heart failure, hepatic mineralocorticoid receptors and blunt Contraindications: cirrhosis, nephrotic syndrome, or aldosterone activity. Hyperkalemia other conditions associated with Chronic renal insufficiency diminished effective intravascular Liver diseases—impaired metabolism of volume). triamterene/spironolactone Strong CYP3A4 inhibitors (Erythromycin, fluconazole, diltiazem and grapefruit juice) can markedly increase blood level of eplerenone but not spironolactone
ENAC Channel blockers
Amiloride -Amiloride and triamterene do not block
aldosterone, but instead directly interfere with Na + entry through the epithelial Na + Triamterene channels (ENaC) in the apical membrane of the collecting tubule. -reduce Na + absorption in the collecting tubules and ducts -Potassium absorption (and K + secretion) at this site is regulated by aldosterone